Can this template be signed electronically?

Yes. Electronic signatures meeting ESIGN Act standards (15 U.S.C. ch. 96) and state UETA rules are generally enforceable. Confirm exceptions such as wills or certain court filings which are excluded from ESIGN/UETA coverage.

Do bioscience forms need HIPAA safeguards?

If the form contains protected health information, HIPAA applies and a Business Associate Agreement is required for vendors handling PHI. Retain records and access logs according to 45 CFR §164.530(j).

When is notarization or witnesses required?

Notarization needs depend on document type and state law. Some states permit Remote Online Notarization; others limit it. For high-assurance authentication, include notarization when required by institutional policy or legal counsel.

What if signer name or ID does not match?

Mismatched names can invalidate identity proofing and require re-execution. Correct the name, obtain a new signature, and retain a short correction affidavit documenting the change.

How long must signed bioscience records be kept?

Retention depends on federal and sponsor rules: IRS records three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), and sponsors or state law may require longer periods. Follow the longest applicable requirement.

How do I revoke or amend a signed template?

To revoke or amend, follow the template's amendment clause and obtain signatures on the amendment. Document revocation with a dated notice and store both the original and amendment in the record set.

Electronic Signature
Templates
Miscellaneous
Bioscience Document Template

Bioscience Document Template

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BIOSCIENCE DOCUMENT TEMPLATE

This Bioscience Services Agreement (the Agreement) is entered into as of between:

Provider Name: Provider Address: Client Name: Client Address:

WHEREAS

WHEREAS, Provider has scientific capabilities, laboratory facilities, and personnel proficient in bioscience methods, assays, and handling of biological materials necessary to perform the services described below; and

WHEREAS, Client desires to retain Provider to perform specified laboratory and research services on the terms and conditions set forth in this Agreement; and

WHEREAS, the parties intend to define responsibilities for the handling, transfer, and use of biological materials, data generation, confidentiality, and allocation of intellectual property arising from the Services.

SCOPE OF WORK

Project Title:

Detailed Scope of Work:

Provider shall perform the services in accordance with applicable biosafety, biosecurity, and regulatory standards, and in conformity with the protocols set forth in the Scope of Work. Any deviation from approved protocols that creates potential safety or regulatory risk shall be promptly reported to Client and may be grounds for immediate suspension of work.

PAYMENT TERMS

Total Fee:

Payment Schedule and Invoicing:

Late Payment: Past due amounts shall accrue interest at or the maximum rate permitted by law, whichever is less. Client shall also reimburse Provider for reasonable collection costs and expenses incurred to collect overdue amounts.

All fees are exclusive of taxes; Client is responsible for any sales, use, value-added, or comparable taxes imposed on payments under this Agreement, except taxes based on Provider's net income.

TERM AND TERMINATION

Term Commencement: Term Expiration:

Either party may terminate this Agreement for convenience upon days' prior written notice. Either party may terminate immediately for material breach that remains uncured after 14 days' written notice, for material safety or regulatory violations, or if continuation of the work creates an imminent hazard.

Upon termination, Client shall pay Provider for all services performed and materials expended through the effective date of termination and for any non-cancellable commitments reasonably incurred by Provider in the performance of the Services.

CONFIDENTIALITY; BIOLOGICAL MATERIALS; DATA

Definition: "Confidential Information" means non-public technical, business, and scientific information disclosed by one party to the other, including protocols, assay methodologies, biological materials, raw and processed data, analyses, and results.

Obligations: The Receiving Party shall keep confidential the Disclosing Party's Confidential Information, shall not use it except to perform under this Agreement, and shall restrict access to those employees, contractors, or agents who have a need to know and who are bound by confidentiality obligations at least as protective as those herein. Confidentiality obligations shall continue for five (5) years from disclosure, except that trade secrets shall be protected for as long as they remain trade secrets under applicable law.

Biological Materials: Title to biological materials provided by Client to Provider remains with Client unless otherwise agreed in writing. Provider shall handle, store, transport and dispose of biological materials and hazardous waste in accordance with applicable biosafety laws, institutional policies, and accepted laboratory practices. Provider shall maintain material transfer records and notify Client promptly of any loss, exposure, or suspected release.

Data and Results: Unless otherwise agreed in writing, Provider shall deliver experimental data and final reports to Client. Ownership of intellectual property and inventions shall be governed by the parties' separate written agreement; absent such an agreement, inventions conceived solely by Provider's personnel in performance of the Services shall be owned by Provider, and inventions conceived solely by Client shall be owned by Client, with joint inventions allocated by lawful joint ownership principles.

Permitted Disclosures to Regulators and Contractors:

Disclosure to Regulatory Authorities as required by law is permitted.
Disclosure to subcontractors performing work under this Agreement is permitted provided subcontractors are bound by confidentiality and biosafety obligations.

COMPLIANCE AND REPRESENTATIONS

Each party represents that it possesses the authority to enter into this Agreement and will comply with all applicable laws, rules, and regulations applicable to its performance, including export controls, biosafety, and human/animal subject protections where applicable. Provider represents that it will perform Services in a professional and workmanlike manner consistent with industry standards.

INDEMNIFICATION

Each party shall indemnify, defend and hold harmless the other from and against any third-party claims, liabilities, losses, damages, and expenses (including reasonable attorneys' fees) arising from its gross negligence, willful misconduct, breach of this Agreement, or its failure to comply with applicable laws and regulations regarding biological materials.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict-of-law principles. Exclusive jurisdiction and venue for disputes shall be the state or federal courts located in the specified state.

ENTIRE AGREEMENT

This Agreement, together with any Statement of Work or written attachments executed by the parties, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals, and communications, whether oral or written. Any amendment or modification must be in writing and signed by authorized representatives of both parties.

NOTICES

Provider Contact: Client Contact:

Provider:

By:

Date:

Client:

By:

Date:

What the Bioscience Document Template Is

A Bioscience Document Template standardizes the structure and required data for laboratory protocols, material transfer agreements, informed consent forms, standard operating procedures, and related research documents. It provides consistent headings, defined fields for parties and samples, and placeholders for signatures and dates so organizations can reduce errors, meet sponsor or regulatory expectations, and produce records suitable for audits or e-submission.

Why a Standard Template Matters for Bioscience Workflows

A consistent template reduces omissions, streamlines internal review, and helps ensure regulatory readiness for audits or inspections. It supports repeatable data capture, faster approvals, and clearer traceability of samples, approvals, and version history.

Typical Users and Teams That Complete This Template

Use by these groups promotes consistent recordkeeping, reduces review cycles, and preserves a defensible audit trail suitable for internal and external review.

Principal investigators and lab managers: prepare protocol metadata, approvals, and sample handling details.
Clinical research coordinators: collect consent, subject IDs, and regulatory approvals for studies.
Quality assurance and compliance teams: ensure version control, audit logs, and retention scheduling.

Essential Parts of a Professional Bioscience Document Template

A complete template organizes metadata, scope, definitions, technical steps, approvals, and signature blocks so reviewers and signers can find and verify required items quickly.

Header

Document title, version number, protocol or project ID, and effective date for clear identification and version control across sites and studies.

Scope

Defines the activities covered, applicable sites, and any exclusions to limit ambiguity during implementation or inspection.

Definitions

Key terms (sample types, assay names, abbreviations) to ensure consistent interpretation by investigators, technicians, and auditors.

Materials

Lists reagents, biospecimen details, storage conditions, and chain-of-custody identifiers necessary for reproducibility and compliance.

Procedures

Stepwise methods, acceptance criteria, safety precautions, and data capture points that technicians must follow and sign off on.

Approvals

Designated signers, role-based signature order, dates, and fields for IRB, QA, and sponsor approvals to document authorization.

Required Information and Fields

Protocol ID: Unique alphanumeric ID

Principal Investigator: Full legal name

Site Address: Street, city, state, ZIP

Sample Identifiers: Barcode or lab ID

Consent Status: Signed / Not signed

Version Date: MM/DD/YYYY format

Stepwise Process to Complete the Template

Follow a defined sequence to minimize rework: gather documents, populate fields, route for review, obtain signatures, and archive the final record.

01

1. Gather Materials: Collect protocols, consents, and sample lists before starting.
02

2. Populate Metadata: Enter protocol ID, dates, PI name, and site information.
03

3. Attach Exhibits: Add SOPs, MSDS, and sponsor attachments as exhibits.
04

4. Route and Sign: Send to approvers in the specified order and capture final signatures.

Where to Send or File This Template During the Workflow

Routing depends on the document type: internal QA, institutional review board, sponsor, and secure archival storage are common destinations.

Upload to LMS/Repository: Store master copy in the lab's document management system.
Route to IRB: Send protocols or consent forms to institutional review board for approval.
Sponsor Submission: Provide sponsor-required documents via sponsor portal when specified.
Archive Final Copy: Preserve signed record in secure retention storage with audit trail.

Technical and Integration Considerations for Digital Completion

Confirm the platform can produce a tamper-evident signed PDF, capture signer attribution and timestamps, and offer audit logs compatible with internal audits or sponsor inspections.

File Formats: PDF, DOCX, HTML supported
Integrations: Salesforce, NetSuite, Google Workspace
Security Standards: TLS 1.2/1.3; AES-256 at rest

How to Configure an Electronic Workflow for This Template

Configure fields, authentication, routing order, and retention settings before sending to avoid corrections after signing.

Field	Configuration
Signature Order	Role-based, sequential or parallel routing
Authentication	Email + SMS OTP or institution SSO
Retention	Set retention period and archival location
Notifications	Automatic reminders and completion notices

Typical Timelines and Processing Expectations

Timelines depend on internal review cycles and external approvals; plan for review, IRB processing, and sponsor signoff when scheduling activities.

Internal Review:

2–4 weeks for QA and compliance checks

IRB Review:

4–12 weeks depending on board schedule

Sponsor Approval:

1–6 weeks per sponsor SLA

Document Archival:

Within 7 days of final signature

Version Control:

Immediate update upon approval to prevent parallel drafts

Common Mistakes to Avoid When Preparing the Template

Mismatched signer names or titles that trigger identity re-verification and delay approvals.
Missing attachments or exhibits that create audit exceptions and require re-submission.
Using inconsistent sample identifiers that break chain-of-custody and invalidate results.
Failing to capture consent versions and dates, complicating regulatory compliance checks.

Penalties and Compliance Risks of Incorrect or Incomplete Templates

HIPAA Exposure: Civil fines possible — 45 CFR §160/164

IRB Sanctions: Study suspension or corrective action

Data Integrity Risk: Invalidated results or rework

Contract Breach: Sponsor penalties or indemnities

Audit Findings: Formal corrective action plans

Sample Loss: Financial loss and reputational harm

Selected eSignature Pricing and Capability Snapshot

This vendor snapshot highlights starting price, trial availability, bulk send, audit trail, HIPAA support, and envelope limits to help compare platforms for bioscience workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day trial	Varies	Varies	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	Yes
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-World Examples of Using eSigned Bioscience Templates

These examples show how organizations capture approvals and maintain compliance using standardized templates and signed records.

Fertility Centers of Illinois

John Butler reported streamlined operations after switching to electronic templates and secure signing.

The platform captured full audit logs and enabled mobile signing.
The result was faster turnaround for patient consent and a consistent recordkeeping approach that met institutional and regulatory expectations without increasing administrative burden.

BIS

Dan Rotelli emphasized compliance-focused platform choice with SOC 2 certification.

Implementation centralized approvals and record retention.
That centralized approach reduced time spent assembling documentation for audits, standardized signature capture, and improved confidence in security and legal defensibility.

Frequently Asked Questions About the Bioscience Document Template

Answers to common questions about signing, notarization, retention, and error correction for bioscience templates.

Need help? Contact support

Can this template be signed electronically?
Yes. Electronic signatures meeting ESIGN Act standards (15 U.S.C. ch. 96) and state UETA rules are generally enforceable. Confirm exceptions such as wills or certain court filings which are excluded from ESIGN/UETA coverage.
Do bioscience forms need HIPAA safeguards?
If the form contains protected health information, HIPAA applies and a Business Associate Agreement is required for vendors handling PHI. Retain records and access logs according to 45 CFR §164.530(j).
When is notarization or witnesses required?
Notarization needs depend on document type and state law. Some states permit Remote Online Notarization; others limit it. For high-assurance authentication, include notarization when required by institutional policy or legal counsel.
What if signer name or ID does not match?
Mismatched names can invalidate identity proofing and require re-execution. Correct the name, obtain a new signature, and retain a short correction affidavit documenting the change.
How long must signed bioscience records be kept?
Retention depends on federal and sponsor rules: IRS records three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), and sponsors or state law may require longer periods. Follow the longest applicable requirement.
How do I revoke or amend a signed template?
To revoke or amend, follow the template's amendment clause and obtain signatures on the amendment. Document revocation with a dated notice and store both the original and amendment in the record set.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now